Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Zoe Moon"'
Autor:
Ayşenur Kılıç, Amy L. Clarke, Zoe Moon, Yohhei Hamada, Amy Hai Yan Chan, Ananna Rahman, Charlotte Layton, Chris J. Griffiths, Dominik Zenner, Ellen Powell, Heinke Kunst, Marc Lipman, Mike Mandelbaum, Padmasayee Papineni, Tessa Tattersall, Trinh Duong, Ibrahim Abubakar, Molebogeng X. Rangaka, Robert Horne
Publikováno v:
Dialogues in Health, Vol 4, Iss , Pp 100162- (2024)
Background: COVID-19 disrupted the TB prevention programme in the UK, especially for TB infection (TBI) care. We explore whether experience of the COVID-19 pandemic impacted on patients' perceptions of TBI and its treatment. Methods: Semi-structured
Externí odkaz:
https://doaj.org/article/99ece33b9633429fbd5d38052e409df5
Autor:
Sarah-Jane F. Stewart, Joanna Slodkowska-Barabasz, Lucy McGeagh, Zoe Moon, Jo Brett, Mary Wells, Morven C. Brown, Mark Turner, Robert Horne, Deborah Fenlon, Farah Rehman, Henry Cain, Peter Donnelly, Victoria Harmer, Lesley Turner, Jan Rose, Linda Sharp, Eila Watson
Publikováno v:
Breast, Vol 70, Iss , Pp 32-40 (2023)
Background: Breast cancer is the most common cancer in women worldwide. Approximately 80% of breast cancers are oestrogen receptor positive (ER+). Patients treated surgically are usually recommended adjuvant endocrine therapy (AET) for 5–10 years.
Externí odkaz:
https://doaj.org/article/8ae4d3efd6ac41388669cbd94784dce6
Autor:
Adam Todd, Catherine Waldron, Lucy McGeagh, Ruth Norris, Iakov Bolnykh, Sarah Jane Stewart, Joanna Slodkowska‐Barabasz, Zoe Moon, Caitriona Cahir, Sue Thompson, Victoria Harmer, Mary Wells, Eila Watson, Linda Sharp, the SWEET Research Team
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Background In oestrogen‐receptor positive breast cancer, daily oral adjuvant endocrine therapy (ET) for at least 5 years significantly reduces risks of recurrence and breast cancer‐specific mortality. However, many women are poorly adher
Externí odkaz:
https://doaj.org/article/512a624bce174ca1acaab137ab4aae62
Autor:
Dominic Stringer, Leanne Gardner, Olivia Shaw, Brendan Clarke, David Briggs, Judith Worthington, Matthew Buckland, Guilherme Danzi, Rachel Hilton, Michael Picton, Raj Thuraisingham, Richard Borrows, Richard Baker, Keith McCullough, John Stoves, Mysore Phanish, Sapna Shah, Kin Yee Shiu, Stephen B. Walsh, Aimun Ahmed, Waqar Ayub, Janet Hegarty, Rose Tinch-Taylor, Evangelos Georgiou, Natalie Bidad, Ayşenur Kılıç, Zoe Moon, Robert Horne, Paul McCrone, Joanna Kelly, Caroline Murphy, Janet Peacock, Anthony Dorling
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101819- (2023)
Summary: Background: 3% of kidney transplant recipients return to dialysis annually upon allograft failure. Development of antibodies (Ab) against human leukocyte antigens (HLA) is a validated prognostic biomarker of allograft failure. We tested whet
Externí odkaz:
https://doaj.org/article/2c4d324f492b41508cbeb5d77c800b2e
Autor:
Lara C.F. Tosunlar, Phuoc Duong, Chris Tack, Jacky Jones, Natali Chung, Joseph Chilcot, Zoe Moon, Alessandra Frigiola
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 6, Iss , Pp 100259- (2021)
Introduction: Medical advancements have significantly improved survival of patients with Congenital Heart Disease (CHD). Consequently, an aging CHD population are more susceptible to cardiac-related complications and co-morbidities.Early intervention
Externí odkaz:
https://doaj.org/article/7c893cce0bf547918f940f03ecb24aa4
Publikováno v:
Healthcare, Vol 10, Iss 12, p 2558 (2022)
Medication adherence to hormone therapy (HT) in breast cancer survivors is often suboptimal and is affected by a range of factors. Patients are usually prescribed different generic formulations of HT drugs and their impact on side effects and on adhe
Externí odkaz:
https://doaj.org/article/1447127c0e004f29b0c1f6d05a708711
Publikováno v:
Psychology & Health. 38:726-765
Nonadherence to medicines is a global problem compromising health and economic outcomes for individuals and society. This article outlines how adherence is defined and measured, and examines the impact, prevalence and determinants of nonadherence. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be84d4b0474ee89e39ea11675263e47
https://doi.org/10.1080/08870446.2022.2144923
https://doi.org/10.1080/08870446.2022.2144923
Publikováno v:
Healthcare, Vol 9, Iss 6, p 688 (2021)
An additional 5 years of treatment with adjuvant hormonal therapy, to complete 10 years of medication, is recommended to reduce the risk of breast cancer recurrence. Yet professionals and patients should balance this benefit against side effects and
Externí odkaz:
https://doaj.org/article/e8d07e85915f44ac8586bdcbb675b25b
Publikováno v:
Journal of Psychosomatic Obstetrics and Gynecology, Vol 38, Iss 3, Pp 226-235 (2017)
Introduction: Menopausal symptoms are frequent and severe in breast cancer survivors taking tamoxifen; however, treatment options are limited for these patients as hormonal replacement therapy is contraindicated. This study aimed to explore the exper
Externí odkaz:
https://doaj.org/article/56631a32a3404b17b1e6bb6d8e4870c4
Publikováno v:
Aesthetic Surgery Journal.
Background Lip filler enhancement has fast become one of the most popular minimally invasive cosmetic procedures. Motivations for “overtreatment” with lip fillers are poorly understood. Objectives The aim of this study was to explore female motiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4fa15f5f56f27486620f224f6d54e93
https://doi.org/10.1093/asj/sjad050
https://doi.org/10.1093/asj/sjad050